2013
DOI: 10.1007/s12020-013-9881-6
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of α-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism

Abstract: The presentation of patients with primary hyperparathyroidism is often atypical and ranges from normocalcemic, primary hyperparathyroidism to severe, symptomatic hypercalcemia. G-protein-coupled, calcium-sensing receptor (CaSR), vitamin D receptor (VDR), and fibroblast growth factor receptor (FGFR)/klotho complexes seem to be involved in the development of pHPT. Parathyroid glands from 53 patients with pHPT and normal parathyroid tissue from 7 patients were obtained during parathyroidectomy. Conventional detai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
17
1
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(20 citation statements)
references
References 28 publications
1
17
1
1
Order By: Relevance
“…Previous studies showed Klotho and CaSR expression were significantly decreased in PTGs of PHTP, SHPT patients, patients after kidney transplantation, and those with end-stage renal disease (55)(56)(57). We could demonstrate a binding interaction between Klotho and CaSR that might play a synergistic effect in controlling PTH synthesis and glandular hyperplasia.…”
Section: Discussionmentioning
confidence: 54%
“…Previous studies showed Klotho and CaSR expression were significantly decreased in PTGs of PHTP, SHPT patients, patients after kidney transplantation, and those with end-stage renal disease (55)(56)(57). We could demonstrate a binding interaction between Klotho and CaSR that might play a synergistic effect in controlling PTH synthesis and glandular hyperplasia.…”
Section: Discussionmentioning
confidence: 54%
“…In a study of primary hyperparathyroid patients, expression of Klotho mRNA and protein was decreased or undetectable in parathyroid adenomas, and the expression was inversely correlated to serum calcium levels [ 44 ]. In another study, the expression of parathyroid Klotho (but not the FGFR) was decreased in patients with primary hyperparathyroidism compared to normal tissue, but there was no correlation between Klotho expression and serum calcium levels [ 45 ]. In uremic patients with secondary hyperparathyroidism, Klotho was detected in nodular parathyroid tissue, but the expression varied in every nodule [ 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…We investigated whether 990G allele affects the interaction of CASR In conclusion, FLNA is variably down-regulated in parathyroid tumors both at mRNA and protein levels. Therefore, parathyroid tumor cells are characterized by receptor and post-receptor defects, namely loss of CASR (Martin-Salvago et al 2003;Yano et al 2003;Haven et al 2004;Kawata et al 2006;Wittenween et al 2011;Latus et al 2013;Varshney et al 2013a), Gq/11 Mingione et al 20 protein (Corbetta et al 2000) Admittedly, our conclusions were limited by the fact that functional experiments were performed in HEK293 cells and could not be replicated in human normal or tumor parathyroid cells.…”
Section: Discussionmentioning
confidence: 90%
“…carcinomas (Haven et al 2004, Wittenveen et al 2011 and primary and secondary hyperplasia (Martin-Salvago et al 2003;Latus et al 2013;Varshney et al 2013a). CASR gene mutations have been rarely identified in sporadic parathyroid tumors (Frank-Raue et al 2011;Guarnieri et al 2010) and CASR gene deregulation is not sustained by promoter hypermethylation (Varshney et al 2013b).…”
Section: Discussionmentioning
confidence: 99%